SCHEMBL1869607

SCHEMBL1869607

Ic1ccccc1Oc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.52
TSHR P16473 2/20 0.52
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.48
KMT2A Q03164 1/20 0.48
HRH1 P35367 1/20 0.45
CTNNB1 P35222 1/20 0.45
ALDH1A1 P00352 2/20 0.44
HTT P42858 2/20 0.44
MAPK1 P28482 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
SLC6A2 P23975 2/20 0.44
SLC6A4 P31645 2/20 0.44
RIPK1 Q13546 1/20 0.44
HPGD P15428 1/20 0.44
KDM1A O60341 2/20 0.42
HTR1A P08908 1/20 0.42
SLC6A3 Q01959 1/20 0.42
DPP4 P27487 1/20 0.42
NR1H2 P55055 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847171 0.92 ALDH1A1 (0.52) LTA4HTSHRLMNAGAAKMT2A
SCHEMBL3843817 0.90 ALDH1A1 (0.50) LTA4HTSHRLMNAGAAKMT2A
SCHEMBL14735414 0.87 NCOA1 (0.47) LTA4HTSHRLMNAGAAKMT2A
SCHEMBL3842333 0.86 GAA (0.44) LTA4HTSHRLMNAGAAKMT2A
SCHEMBL3843390 0.86 ALDH1A1 (0.46) LTA4HTSHRLMNAGAAKMT2A
SCHEMBL3845391 0.85 ALDH1A1 (0.50) LTA4HTSHRLMNAGAAKMT2A
SCHEMBL9322660 0.84 LMNA (0.48) LTA4HTSHRLMNAGAAKMT2A
SCHEMBL3845701 0.84 CA12 (0.38) LTA4HTSHRKMT2AALDH1A1HTT
SCHEMBL23674204 0.82 SLC6A4 (0.50) TSHRLMNAGAAKMT2AALDH1A1
SCHEMBL17579576 0.82 ALDH1A1 (0.39) LTA4HTSHRLMNAGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007117482-A2 RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-10-18 WO claimed
JP-63099029-A None JP disclosed
WO-2026086794-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF THE CHINESE UNIVERSITY OF HONG KONG (CN) 2026-04-30 WO disclosed
CN-114981254-B Compound for organic electronic element, organic electronic element using the same, and electronic device having the same 德山新勒克斯有限公司 2025-06-24 CN disclosed
CN-112794833-B Blue light dye compound and application thereof 石家庄诚志永华显示材料有限公司 2023-12-26 CN disclosed
CN-114957229-B Aromatic amine compound and application thereof 广州追光科技有限公司 2023-11-24 CN disclosed
CN-112794804-B Spirofluorene derivative and application thereof 石家庄诚志永华显示材料有限公司 2023-10-24 CN disclosed
CN-112830902-B Heterocyclic spirofluorene compounds and uses thereof 石家庄诚志永华显示材料有限公司 2023-09-29 CN disclosed
US-20230287011-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-09-14 US disclosed
CN-116554202-A Nitrogen-containing condensed ring compound and application thereof in organic electroluminescent device 北京绿人科技有限责任公司 2023-08-08 CN disclosed
US-5763636-A CONJUGATED POLYCYCLIC POLYMERS HOECHST AKTIENGESELLSCHAFT (DE) 1998-06-09 US disclosed
EP-0236348-B1 CARBONYLATION PROCESS FOR THE PRODUCTION OF AROMATIC ACIDS EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1990-05-02 EP disclosed
JP-S6399029-A HYDROLYSIS OF AROMATIC IODIDE ASAHI CHEM IND CO LTD 1988-04-30 JP disclosed
EP-0236348-A1 CARBONYLATION PROCESS FOR THE PRODUCTION OF AROMATIC ACIDS. EASTMAN KODAK CO (US) 1987-09-16 EP disclosed
US-4649216-A Carbonylation process for the production of aromatic acids EASTMAN KODAK COMPANY (US) 1987-03-10 US disclosed
WO-1987000829-A1 CARBONYLATION PROCESS FOR THE PRODUCTION OF AROMATIC ACIDS EASTMAN KODAK COMPANY (US) 1987-02-12 WO disclosed
US-4613620-A MICROBIOCIDES ELI LILLY AND COMPANY (US) 1986-09-23 US disclosed
US-4567280-A NITROGEN DIOXIDE; BY-PRODUCT INHIBITION UBE INDUSTRIES, LTD. (JP) 1986-01-28 US disclosed
US-4283349-A MICROBIOCIDES ELI LILLY AND COMPANY (US) 1981-08-11 US disclosed
US-4193935-A Novel oxiodinium and thiaiodinium compounds ELI LILLY AND COMPANY (US) 1980-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287011-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OXGR1, OCIAD1 LTA4H 1855/4885TSHR 398/4885LMNA 2368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.